Medication info

Unitab 5 mg (Linagliptin)

Prescription medicationTabletExpired
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Korea Union Pharm Co., Ltd.
Appearance
Bright red round film-coated tablets
Packaging
30 tablets/box [(10 tablets/Alu-Alu×3)], 30 tablets/bottle
Approval status
Expired

MFDS item code 202003323 · Approved 2020.05.07

This product's status changed to Expired on 2025.05.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5mg once daily. It may be administered regardless of meals. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Korea Union Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with Type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with Type 2 diabetes. It can be administered as a standalone therapy for initial treatment, and if blood sugar control is challenging with monotherapy, it can be taken in combination with metformin or sulfonylureas. Additionally, if blood sugar control is still insufficient with insulin therapy or multiple drug combinations, this medication may be added. It helps improve blood sugar management at various stages of treatment to maintain a healthy blood sugar state.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5mg once daily. It may be administered regardless of meals. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be required to minimize the risk of hypoglycemia.

Precautions

This medication should not be used by individuals who have an allergic reaction to this drug's active ingredient or other components. It is also safe not to administer to patients with Type 1 diabetes or diabetic ketoacidosis. Caution is necessary when used with insulin or sulfonylurea as they can cause hypoglycemia, as this may increase the risk of low blood sugar. In patients with heart failure, caution should be exercised for those with mild to moderate severity, and it is not recommended for patients with severe heart failure. There is a risk of acute pancreatitis, so if severe abdominal pain or similar symptoms occur, discontinue the medication immediately and consult a physician. During the use of this medication, bullous skin disease such as pemphigoid may appear, so if any unusual skin symptoms occur, stop taking the medication immediately and seek medical attention from a specialist. This medication can cause hypoglycemic symptoms, so it is essential to be well-informed about the symptoms of low blood sugar, especially when using it in combination with other hypoglycemic agents. Pregnant or nursing women should avoid using this medication as its safety is not established. There have not been sufficient clinical trials in children and adolescents, so it is not recommended for these groups. For elderly patients, no significant dose adjustment is required, but they should follow their physician's instructions based on their condition. Patients with decreased kidney or liver function can use it without dose adjustments, but their condition should be closely monitored. In the case of overdose, the remaining medication in the gastrointestinal tract should be removed, symptoms should be monitored, and appropriate treatment should be provided if necessary. This medication has a low risk of interaction with other drugs, but it is safe to consult a physician or pharmacist when used with specific medications. Keep out of the reach of children and do not transfer to other containers.

Side effects

  • Hypoglycemia
  • hypersensitivity
  • angioedema
  • urticaria
  • cough
  • pancreatitis
  • constipation
  • oral ulcers
  • rash
  • dermatitis herpetiformis
Show 135 more
  • severe and disabling arthralgia
  • rhabdomyolysis
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial edema
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • decreased appetite
  • cerebral infarction
  • speech impairment
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • fatigue
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscal injury
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • dizziness
  • sensory loss
  • chest discomfort
  • weakness
  • pain
  • nosebleed
  • oropharyngeal pain
  • voice disorder
  • allergic rhinitis
  • exercise-induced dyspnea
  • wet cough
  • runny nose
  • pulmonary mass
  • arthralgia
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • increased serum triglycerides
  • increased urine albumin/creatinine ratio
  • positive urine leukocytes
  • decreased hemoglobin
  • increased serum potassium
  • increased serum creatinine
  • increased serum creatine phosphokinase
  • increased ALT
  • increased serum triglycerides
  • androgenetic alopecia
  • diabetic foot syndrome
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • mood disorders
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • glaucoma
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • hepatic steatosis
  • hearing loss
  • erectile dysfunction
  • thyroid goiter
  • pruritus
  • hypertension
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Bright red round film-coated tablets

Package unit

30 tablets/box [(10 tablets/Alu-Alu×3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.